nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—Abnormal faeces—Hydrochlorothiazide—nephrolithiasis	0.0283	0.0444	CcSEcCtD
Rabeprazole—ATP4B—Ion channel transport—CLCN5—nephrolithiasis	0.0227	0.0904	CbGpPWpGaD
Rabeprazole—ATP4B—Ion channel transport—CLCN4—nephrolithiasis	0.0227	0.0904	CbGpPWpGaD
Rabeprazole—ATP4A—Ion channel transport—CLCN4—nephrolithiasis	0.0203	0.0805	CbGpPWpGaD
Rabeprazole—ATP4A—Ion channel transport—CLCN5—nephrolithiasis	0.0203	0.0805	CbGpPWpGaD
Rabeprazole—CYP2C19—urine—nephrolithiasis	0.017	0.153	CbGeAlD
Rabeprazole—Sinus bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0165	0.0259	CcSEcCtD
Rabeprazole—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0154	0.0241	CcSEcCtD
Rabeprazole—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0154	0.0241	CcSEcCtD
Rabeprazole—CYP1A2—urine—nephrolithiasis	0.0139	0.125	CbGeAlD
Rabeprazole—CYP2C9—urine—nephrolithiasis	0.0132	0.119	CbGeAlD
Rabeprazole—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.012	0.0188	CcSEcCtD
Rabeprazole—ATP4A—renal system—nephrolithiasis	0.0119	0.107	CbGeAlD
Rabeprazole—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0184	CcSEcCtD
Rabeprazole—ATP4A—kidney—nephrolithiasis	0.0115	0.104	CbGeAlD
Rabeprazole—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0176	CcSEcCtD
Rabeprazole—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0166	CcSEcCtD
Rabeprazole—CYP3A4—urine—nephrolithiasis	0.0101	0.0906	CbGeAlD
Rabeprazole—CYP2D6—urine—nephrolithiasis	0.00991	0.0892	CbGeAlD
Rabeprazole—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.00913	0.0143	CcSEcCtD
Rabeprazole—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.00901	0.0141	CcSEcCtD
Rabeprazole—Gout—Hydrochlorothiazide—nephrolithiasis	0.00865	0.0136	CcSEcCtD
Rabeprazole—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.00854	0.0134	CcSEcCtD
Rabeprazole—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.00843	0.0132	CcSEcCtD
Rabeprazole—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00808	0.0127	CcSEcCtD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00792	0.0314	CbGpPWpGaD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00792	0.0314	CbGpPWpGaD
Rabeprazole—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00738	0.0116	CcSEcCtD
Rabeprazole—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0073	0.0115	CcSEcCtD
Rabeprazole—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0073	0.0115	CcSEcCtD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00706	0.028	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00706	0.028	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00706	0.028	CbGpPWpGaD
Rabeprazole—ABCG2—Iron uptake and transport—ATP6V0A4—nephrolithiasis	0.007	0.0278	CbGpPWpGaD
Rabeprazole—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00677	0.0106	CcSEcCtD
Rabeprazole—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00674	0.0106	CcSEcCtD
Rabeprazole—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00668	0.0105	CcSEcCtD
Rabeprazole—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00668	0.0105	CcSEcCtD
Rabeprazole—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00662	0.0104	CcSEcCtD
Rabeprazole—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0065	0.0102	CcSEcCtD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00645	0.0256	CbGpPWpGaD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00645	0.0256	CbGpPWpGaD
Rabeprazole—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00632	0.00992	CcSEcCtD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00629	0.025	CbGpPWpGaD
Rabeprazole—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00624	0.0098	CcSEcCtD
Rabeprazole—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00616	0.00967	CcSEcCtD
Rabeprazole—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00603	0.00947	CcSEcCtD
Rabeprazole—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00589	0.00924	CcSEcCtD
Rabeprazole—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00586	0.0092	CcSEcCtD
Rabeprazole—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00582	0.00913	CcSEcCtD
Rabeprazole—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00577	0.00906	CcSEcCtD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00575	0.0228	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00575	0.0228	CbGpPWpGaD
Rabeprazole—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00566	0.00889	CcSEcCtD
Rabeprazole—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00541	0.0085	CcSEcCtD
Rabeprazole—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00538	0.00844	CcSEcCtD
Rabeprazole—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00536	0.00841	CcSEcCtD
Rabeprazole—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00534	0.00838	CcSEcCtD
Rabeprazole—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00528	0.00829	CcSEcCtD
Rabeprazole—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00519	0.00815	CcSEcCtD
Rabeprazole—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00517	0.00812	CcSEcCtD
Rabeprazole—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.0051	0.00801	CcSEcCtD
Rabeprazole—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00507	0.00795	CcSEcCtD
Rabeprazole—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00497	0.0078	CcSEcCtD
Rabeprazole—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00494	0.00775	CcSEcCtD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00489	0.0194	CbGpPWpGaD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00489	0.0194	CbGpPWpGaD
Rabeprazole—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00474	0.00744	CcSEcCtD
Rabeprazole—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00474	0.00744	CcSEcCtD
Rabeprazole—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00468	0.00735	CcSEcCtD
Rabeprazole—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00467	0.00733	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00463	0.00726	CcSEcCtD
Rabeprazole—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00461	0.00724	CcSEcCtD
Rabeprazole—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00457	0.00718	CcSEcCtD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00455	0.0181	CbGpPWpGaD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00455	0.0181	CbGpPWpGaD
Rabeprazole—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00455	0.00713	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00448	0.00703	CcSEcCtD
Rabeprazole—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00445	0.00699	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00443	0.00695	CcSEcCtD
Rabeprazole—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00443	0.00695	CcSEcCtD
Rabeprazole—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00441	0.00691	CcSEcCtD
Rabeprazole—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00439	0.00689	CcSEcCtD
Rabeprazole—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00439	0.00689	CcSEcCtD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00436	0.0173	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00436	0.0173	CbGpPWpGaD
Rabeprazole—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00433	0.0068	CcSEcCtD
Rabeprazole—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00431	0.00676	CcSEcCtD
Rabeprazole—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00426	0.00669	CcSEcCtD
Rabeprazole—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00424	0.00665	CcSEcCtD
Rabeprazole—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00422	0.00662	CcSEcCtD
Rabeprazole—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00413	0.00648	CcSEcCtD
Rabeprazole—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00407	0.00638	CcSEcCtD
Rabeprazole—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00406	0.00637	CcSEcCtD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00405	0.0161	CbGpPWpGaD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00405	0.0161	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00405	0.0161	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00405	0.0161	CbGpPWpGaD
Rabeprazole—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00403	0.00632	CcSEcCtD
Rabeprazole—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.004	0.00627	CcSEcCtD
Rabeprazole—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00391	0.00614	CcSEcCtD
Rabeprazole—ABCG2—nephron tubule—nephrolithiasis	0.00389	0.035	CbGeAlD
Rabeprazole—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00384	0.00602	CcSEcCtD
Rabeprazole—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00378	0.00594	CcSEcCtD
Rabeprazole—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00362	0.00569	CcSEcCtD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00361	0.0143	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00361	0.0143	CbGpPWpGaD
Rabeprazole—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00358	0.00563	CcSEcCtD
Rabeprazole—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00353	0.00554	CcSEcCtD
Rabeprazole—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00348	0.00546	CcSEcCtD
Rabeprazole—Tension—Hydrochlorothiazide—nephrolithiasis	0.00347	0.00544	CcSEcCtD
Rabeprazole—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00346	0.00543	CcSEcCtD
Rabeprazole—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00343	0.00538	CcSEcCtD
Rabeprazole—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00342	0.00536	CcSEcCtD
Rabeprazole—CYP1A2—renal system—nephrolithiasis	0.0034	0.0306	CbGeAlD
Rabeprazole—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0034	0.00533	CcSEcCtD
Rabeprazole—CYP1A1—renal system—nephrolithiasis	0.00336	0.0302	CbGeAlD
Rabeprazole—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00333	0.00522	CcSEcCtD
Rabeprazole—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00331	0.00519	CcSEcCtD
Rabeprazole—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00328	0.00514	CcSEcCtD
Rabeprazole—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00326	0.00512	CcSEcCtD
Rabeprazole—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00325	0.00509	CcSEcCtD
Rabeprazole—CYP1A1—kidney—nephrolithiasis	0.00324	0.0292	CbGeAlD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00324	0.0129	CbGpPWpGaD
Rabeprazole—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00323	0.00506	CcSEcCtD
Rabeprazole—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00318	0.005	CcSEcCtD
Rabeprazole—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00317	0.00498	CcSEcCtD
Rabeprazole—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00317	0.00497	CcSEcCtD
Rabeprazole—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00316	0.00496	CcSEcCtD
Rabeprazole—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00312	0.0049	CcSEcCtD
Rabeprazole—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0031	0.00487	CcSEcCtD
Rabeprazole—Cough—Hydrochlorothiazide—nephrolithiasis	0.00308	0.00484	CcSEcCtD
Rabeprazole—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00301	0.00472	CcSEcCtD
Rabeprazole—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00301	0.00472	CcSEcCtD
Rabeprazole—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00301	0.00472	CcSEcCtD
Rabeprazole—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.003	0.0047	CcSEcCtD
Rabeprazole—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00297	0.00466	CcSEcCtD
Rabeprazole—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00294	0.00461	CcSEcCtD
Rabeprazole—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00291	0.00456	CcSEcCtD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00289	0.0115	CbGpPWpGaD
Rabeprazole—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00288	0.00452	CcSEcCtD
Rabeprazole—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00288	0.00452	CcSEcCtD
Rabeprazole—Shock—Hydrochlorothiazide—nephrolithiasis	0.00284	0.00445	CcSEcCtD
Rabeprazole—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00282	0.00443	CcSEcCtD
Rabeprazole—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00281	0.00441	CcSEcCtD
Rabeprazole—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00279	0.00437	CcSEcCtD
Rabeprazole—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00275	0.00431	CcSEcCtD
Rabeprazole—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00269	0.00423	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00263	0.00412	CcSEcCtD
Rabeprazole—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00261	0.00409	CcSEcCtD
Rabeprazole—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00259	0.00406	CcSEcCtD
Rabeprazole—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00257	0.00403	CcSEcCtD
Rabeprazole—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00402	CcSEcCtD
Rabeprazole—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00254	0.00398	CcSEcCtD
Rabeprazole—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00251	0.00393	CcSEcCtD
Rabeprazole—Pain—Hydrochlorothiazide—nephrolithiasis	0.00246	0.00387	CcSEcCtD
Rabeprazole—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00246	0.00387	CcSEcCtD
Rabeprazole—CYP3A4—renal system—nephrolithiasis	0.00246	0.0222	CbGeAlD
Rabeprazole—CYP2D6—renal system—nephrolithiasis	0.00242	0.0218	CbGeAlD
Rabeprazole—CYP3A4—kidney—nephrolithiasis	0.00238	0.0214	CbGeAlD
Rabeprazole—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00238	0.00373	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00236	0.0037	CcSEcCtD
Rabeprazole—CYP2D6—kidney—nephrolithiasis	0.00234	0.0211	CbGeAlD
Rabeprazole—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00229	0.00359	CcSEcCtD
Rabeprazole—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00228	0.00358	CcSEcCtD
Rabeprazole—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00228	0.00358	CcSEcCtD
Rabeprazole—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00212	0.00333	CcSEcCtD
Rabeprazole—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00207	0.00325	CcSEcCtD
Rabeprazole—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00204	0.0032	CcSEcCtD
Rabeprazole—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00197	0.00309	CcSEcCtD
Rabeprazole—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.00191	0.00759	CbGpPWpGaD
Rabeprazole—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00191	0.00299	CcSEcCtD
Rabeprazole—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00183	0.00288	CcSEcCtD
Rabeprazole—Rash—Hydrochlorothiazide—nephrolithiasis	0.00182	0.00285	CcSEcCtD
Rabeprazole—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00182	0.00285	CcSEcCtD
Rabeprazole—Headache—Hydrochlorothiazide—nephrolithiasis	0.00181	0.00283	CcSEcCtD
Rabeprazole—CYP1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00175	0.00697	CbGpPWpGaD
Rabeprazole—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00171	0.00269	CcSEcCtD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00165	0.00654	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00165	0.00654	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00147	0.00583	CbGpPWpGaD
Rabeprazole—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.00144	0.0057	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00134	0.00533	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00134	0.00533	CbGpPWpGaD
Rabeprazole—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00132	0.00524	CbGpPWpGaD
Rabeprazole—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.00131	0.0052	CbGpPWpGaD
Rabeprazole—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.00112	0.00444	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00102	0.00404	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00102	0.00404	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000946	0.00376	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000946	0.00376	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000863	0.00343	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000843	0.00335	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000843	0.00335	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000674	0.00268	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GRHPR—nephrolithiasis	0.000585	0.00232	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AGXT—nephrolithiasis	0.000521	0.00207	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—APRT—nephrolithiasis	0.000443	0.00176	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—SLC26A1—nephrolithiasis	0.000443	0.00176	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GRHPR—nephrolithiasis	0.000396	0.00157	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AGXT—nephrolithiasis	0.000353	0.0014	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GRHPR—nephrolithiasis	0.000324	0.00129	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AQP1—nephrolithiasis	0.000316	0.00125	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—SLC26A1—nephrolithiasis	0.0003	0.00119	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—APRT—nephrolithiasis	0.0003	0.00119	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000298	0.00118	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000295	0.00117	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AGXT—nephrolithiasis	0.000289	0.00115	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CHRM3—nephrolithiasis	0.000286	0.00113	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000265	0.00105	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000263	0.00105	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.000252	0.001	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—APRT—nephrolithiasis	0.000245	0.000975	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	0.000245	0.000975	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000226	0.000897	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000226	0.000897	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.000225	0.000893	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—APRT—nephrolithiasis	0.000224	0.000889	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.000224	0.000889	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AQP1—nephrolithiasis	0.000214	0.000849	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000195	0.000773	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CHRM3—nephrolithiasis	0.000193	0.000768	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	0.000191	0.00076	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—APRT—nephrolithiasis	0.000191	0.00076	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AQP1—nephrolithiasis	0.000175	0.000695	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000174	0.000689	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000161	0.000639	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AQP1—nephrolithiasis	0.000159	0.000633	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CHRM3—nephrolithiasis	0.000158	0.000628	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000148	0.000586	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000148	0.000586	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000145	0.000578	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CHRM3—nephrolithiasis	0.000144	0.000573	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AQP1—nephrolithiasis	0.000136	0.000541	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CHRM3—nephrolithiasis	0.000123	0.000489	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AQP1—nephrolithiasis	0.000105	0.000418	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CHRM3—nephrolithiasis	9.51e-05	0.000378	CbGpPWpGaD
